PBE
$81.39
Invesco Biotechnology & Genome ETF
ENDING SOONFirst 100 Only
Help Us Build Premium ETF Tools
4 quick questions • Get LIFETIME free access
Worth $2,400→ FREE
Explore sections
1 Month
+10.25%
YTD
+16.03%
1 Year
+16.03%
3 Year
+26.62%
Top 10 Holdings (47.9% of portfolio)
- Alnylam Pharmaceuticals Inc6.70%
- Illumina Inc6.17%
- Amgen Inc5.23%
- Gilead Sciences Inc5.10%
- Vertex Pharmaceuticals Inc5.07%
- BioMarin Pharmaceutical Inc4.93%
- United Therapeutics Corp4.32%
- Anavex Life Sciences Corp4.14%
- Protagonist Therapeutics Inc3.13%
- Incyte Corp3.10%
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals Inc | ALNY | Health Care | 6.70% |
| 2 | Illumina Inc | ILMN | Health Care | 6.17% |
| 3 | Amgen Inc | AMGN | Health Care | 5.23% |
| 4 | Gilead Sciences Inc | GILD | Health Care | 5.10% |
| 5 | Vertex Pharmaceuticals Inc | VRTX | Health Care | 5.07% |
| 6 | BioMarin Pharmaceutical Inc | BMRN | Health Care | 4.93% |
| 7 | United Therapeutics Corp | UTH | Health Care | 4.32% |
| 8 | Anavex Life Sciences Corp | AVXL | Health Care | 4.14% |
| 9 | Protagonist Therapeutics Inc | PTGX | Health Care | 3.13% |
| 10 | Incyte Corp | INCY | Health Care | 3.10% |
Similar ETFs(in Health Care sector)
Help Us Improve ETF Tools
Share your feedback and get early access to new features
Quick 2-minute survey→ FREE